KEYMED BIO-Bに関するコメント

$KEYMED BIO-B(02162.HK)$ Short-term share prices are hard to pin down. I remember that in 19 years, Cinda was over 20 billion for a whole year and broke 100 billion in 20 years. In November last year, Kangfang fell to more than 10 billion yuan and rose back to 30 billion yuan in a month or two. In April this year, Corning & Jerry's was only more than 8 billion yuan at its worst, and broke 20 billion yuan in one or two months. Konoya is now left time, firmly optimistic about the first half of next year to stand at $20 billion.